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This study was conducted to examine mood state and quality of life (QOL) in patients who had 
undergone a mastectomy. The study used a descriptive design and was conducted in outpatient 
oncology clinics in northeastern Iran. Using the Profile of Mood States and the Ferrans and Powers 
Quality of Life Index, the mood state and QOL of patients who had undergone a mastectomy were 
examined. The results indicate that participants had low mood state and QOL; in addition, a nega-
tive correlation was found between the two. The mood state was a predictor of participants’ QOL. 
A screening system for patients who have undergone a mastectomy may help nurses evaluate patients’ 
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Quality of Life and Mood State 
in Iranian Women Post Mastectomy
T
he lifetime risk of breast cancer among women in 
the United States is 13% (National Cancer Institute, 
2010), making breast cancer one of the most com-
mon cancers for this demographic (Karakoyun-Celik 
et al., 2010). Breast cancer is also the most common 
cancer among Iranian women, accounting for 24% of all female- 
affected cancers in Iran (Hagh Azali et al., 2007; Mousavi et 
al., 2009). Because the majority of cases are diagnosed in later 
stages, mastectomy procedures are the most common treat-
ment for this type of cancer in Iran (Najafi, Ebrahimi, Kaviani, 
Hashemi, & Montazeri, 2005). The treatment of breast can-
cer, even in the later stages of the disease, can lead to sur-
vival rates of a few years, which, in turn, focuses attention to 
patients’ quality of life (QOL) during those additional years 
(Rabin, Heldt, Hirakata, & Fleck, 2008).
QOL is a complex, multidimensional assessment of the physi-
cal, psychological, and social well-being of individuals (Akin, 
Can, Durna, & Aydiner, 2008) and is an important outcome 
measure for patients with cancer (Takahashi et al., 2008). Can-
cer widely and negatively affects patients’ QOL in all physical, 
psychological, and social aspects. In several studies, patients 
© iStockphoto.com/Alex Croft
with breast cancer reported a low QOL after a mastectomy 
(Manganiello, Hoga, Reberte, Miranda, & Rocha, 2011; Montaz-
eri et al., 2008; Robb et al., 2007; Weitzner, Meyers, Stuebing, & 
Saleeba, 1997). According to Rabin et al. (2008), among patients 
who had undergone a mastectomy, the lowest QOL scores 
belonged to the domains of physical, psychological, and de-
pressive symptoms. The loss of one or both breasts may evoke 
feelings of altered body image and mutilation, diminished 
self-worth, loss of a sense of feminity,  and decreased feelings 
of sexual attractiveness and function, as well as mood disor-
ders (Han, Grothuesmann, Neises, Hille, & Hillemanns, 2010; 
Manganiello et al., 2011). Anxiety and depression are the most 
prevalent psychological symptoms reported by patients with 
cancer (Takahashi et al., 2008), with the reported prevalence 
ranging from 13%–54% (Hopwood, Haviland, Mills, Sumo, & 
Bliss, 2007; Takahashi et al., 2008).
Mehnert and Koch (2008) found depression and anxiety 
among women who had undergone a mastectomy and were 
monitored at least one year after the diagnosis. However, other 
studies reported generally positive psychosocial outcomes 
after a mastectomy (Geiger et al., 2007; Shi et al., 2011). The 
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contradictive results warrant additional studies on the QOL of 
women who had mastectomies and the psychological aspects 
throughout evaluation. In the Iranian context, limited studies 
were found that examined the mood state and QOL of women 
who had undergone a mastectomy. This cross-sectional study 
was conducted to examine the mood state and QOL of these 
patients in northeastern Iran.
Methods
The study employed a descriptive design. Women who had 
undergone a mastectomy and were referred to outpatient 
oncology clinics for routine follow-up in Mashhad, Iran, were 
included in this study (N = 50). None of the women were in 
active treatment at the time of study accrual. To be eligible for 
this study, participants were required to meet the following 
criteria: (a) were 1–5 years post surgery; (b) were in stage I, II, 
or III of the disease; (c) had a modified radical mastectomy; (d) 
were not in active treatment; (e) were monitored for at least 
12 months without local, regional, and distant recurrence; (f) 
had at least a sixth-grade education; (g) were age 70 years or 
younger, and (h) provided informed consent. A psychiatrist 
screened each woman to determine that the participants did 
not have a history of psychiatric diagnoses.
Instruments
A questionnaire, developed by the authors, was designed to 
obtain background information that was assumed to influence 
the participants’ mood and QOL, including age, level of educa-
tion, and stage of breast cancer.
Participants completed two standardized assessment instru-
ments, the Profile of Mood State (POMS) and the Ferrans and 
Powers Quality of Life Index (FPQLI), measuring mood and 
QOL, respectively. The POMS is a 65-item questionnaire with 
six components: anxiety, anger, fatigue, depression, vigor, and 
confusion. Each component was scored and the total score was 
calculated by adding the scores from anxiety, anger, fatigue, 
depression, and confusion and then subtracting the vigor score. 
The items were graded from 0 (not at all) to 4 (extremely), giv-
ing a value range from –24 to 177, with higher scores indicating 
a greater disturbance in mood (McNair, Lorr, & Droppleman, 
1971).
The FPQLI is a multidimensional, self-administered rating 
scale that consists of 66 items in two parts. Part I measures 
the participants’ satisfaction in four domains of their life: 
health functioning, socioeconomic aspects, psychological and 
spiritual aspects, and family. Part II measures the participants’ 
views about the importance of those four aspects of life. The 
questions in both parts were graded from 1 (part I: very disat-
isfied; part II: very unimportant) to 6 (part I: very satisfied; 
part II: very important), which will give a value from 0–30, with 
higher scores indicating better QOL (Ferrans & Powers, 1992).
For translation of both questionnaires from English into 
Farsi, the standard forward-backward procedure was applied. 
Translation of the items and the response categories were 
independently performed by two professional translators and 
then temporary versions were provided. Then, they were back 
translated into English, and, after a careful cultural adaptation, 
the final versions were provided. Translated questionnaires 
went through pilot testing.
Studies have provided evidence for validity and reliability of 
the POMS (Debess, Riis, Pedrsen, & Ewertz, 2009; McNair et al., 
1971) and the FPQLI (Brandberg et al., 2008; McNair et al., 1971; 
Weitzner et al., 1997); however, no evidence exists in Iran, so the 
validity and reliability of both scales were rechecked through a 
face validity. Ten faculty members in the Nursing School at Mash-
had University reviewed the content of the scales from a cultural 
perspective. They agreed that translated questionnaires were 
culturally adapted within the research context. To reassess the 
reliability of both translated scales, alpha coefficients of internal 
consistency (N = 20) were computed. The alpha coefficients 
were 0.81 for POMS and 0.93 for FPQOLI, reflecting acceptable 
reliability and validity.
Data Collection and Analysis
Approval for this study was obtained from the institutional 
review board at Mashhad University of Medical Science prior 
to implementation of the study. All participants were provided 
with a full explanation of the study and invited to participate. 
Confidentiality and anonymity were strictly observed. In-
formed consent to participate was obtained from all partici-
pants. Patients were told that they had the right to withdraw at 
any time throughout the study, and nonparticipation would not 
have any detrimental effects in terms of the essential or regular 
hospital treatments and services received.
Participants were recruited from outpatient oncology clinics 
and were identified by the physician. Eligible patients were con-
tacted by telephone. Those who agreed to participate were met 
in a waiting room or a small private room while they waited to be 
seen by the physician who outlined the purpose of the study. If a 
patient understood the study and agreed to participate, she signed 
a consent form. Instruments, as well as a background information 
form, then were administered by the first researcher, and respon-
dents were asked to complete questionnaires.
TABLE 1. Demographic Characteristics
Variable n
Age (years)
 20–34 6
 35–49 23
 50–69 21
Level of education
 Primary 20
 Secondary 21
 College 9
Marital status
 Married 44
 Never married 6
Employment status
 Unemployed 40
 Employed 10
N = 50
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SPSS® for Windows®, version 17.0, was used to analyze the 
data. Descriptive statistics were computed for the study vari-
ables. To examine the correlation between the scales’ scores, 
the Pearson correlation coefficient was used. A general linear 
model was conducted to determine possible predictors for QOL 
and mood. One-way analysis of variance (ANOVA) was per-
formed to check the effect of breast cancer stage on QOL and 
mood. The significance level considered was 0.05 (two-tailed). 
Results
The mean age of the participants was 47.3 (SD = 8.62), and their 
demographic characteristics are listed in Table 1. Participants 
reported low mean scores in all subscales of the POMS (total 
—
X     = 
55.46) as well as the FPQLI (total 
—
X     = 16.74) (see Table 2).
Possible Predictors
The second analysis with the general linear model was 
conducted on women who had undergone a mastectomy 
without the cancer stage. Potential predictors of the total 
scores of the FPQLI were age, education, marital status, 
employment status, and the POMS. The POMS was predic-
tive for total scores of QOL, meaning the greater the mood 
disturbance, the poorer QOL reported (R2 = 0.67; p = 0.007). 
The third analysis with the general linear model was con-
ducted on participants by factoring in the stage of cancer to 
see whether it affected the predictive equation. In this model, 
age and education were not predictive of QOL. Adding stage 
of cancer as a predictor of QOL showed that it was a predictor 
of QOL, meaning the higher stage of breast cancer, the poorer 
QOL reported (R2 = 0.77; p = 0.001). According to one-way 
ANOVA, patients with stage III cancer had the lowest QOL (p = 
0.024) and most mood disturbance (p = 0.015) (see Table 3). 
Pearson correlation coefficient indicated a negative correlation 
between the POMS and FPQOLI scores among participants, 
meaning the greater the mood disturbance, the poorer QOL 
reported (r = –0.598; p < 0.001)
Limitations
The study had several limitations that should be considered 
with the first being the cross-sectional nature of this study. 
The prospective designs are more confident where mood is a 
valid predictor of future QOL in patients who had undergone 
a mastectomy. The second limitation is the co-relational nature 
of the study, which raises the possibility that compounding 
variables influence both mood state and QOL of patients. In 
addition, use of the self-report questionnaires may have led to 
an overestimation of some of the findings because of variance 
in shared method. Because the study was done in the Iranian 
context, the results might not be applicable for women living 
in other countries with different healthcare systems.
Discussion
The results of this study indicated a high incidence of 
mood disturbances (e.g., anxiety, anger, fatigue, depression, 
vigor, confusion) among Iranian women who had undergone 
a mastectomy. Weitzner et al. (1997) used the Beck Depres-
sion Inventory and the State-Trait Anxiety Inventory and 
also found that patients who had undergone a mastectomy 
experienced high levels of anxiety and depression. Using the 
Hospital Anxiety and Depression Scale, Mehnert and Koch 
(2008) found a higher level of anxiety in cancer survivors 
compared to normative comparison groups. Based on the 
findings, participants had low scores in all aspects of QOL, 
which is consistent with previous studies conducted among 
patients with breast cancer who had undergone a mastectomy 
(Mehnert & Koch, 2008; Montazeri et al., 2008; Rabin et al., 
2008; Robb et al., 2007; Weitzner et al., 1997). However, some 
studies found an improvement in the QOL of breast cancer 
survivors after undergoing a mastectomy (Brandberg et al., 
2008; Geiger et al., 2007; Shi et al., 2011). The contrast in find-
ings could be caused by differing instruments, sample sizes, 
and characteristics. Geiger et al. (2007) used the European 
Organisation for the Research and Treatment of Cancer Quality 
of Life Questionnaire–Core 30 to examine the QOL of patients 
with breast cancer. Brandberg et al. (2008) used the Swedish 
Short Term-36 Health Survey to assess the QOL of patients with 
breast cancer in Sweden.
The results of the current study indicated a negative correla-
tion between the POMS and FPQOLI, which meant that the 
TABLE 2. Mood States and Quality-of-Life Scores
Scale
—
X    SD
Profile of Mood Statesa
 Anxiety 17.82 9.72
 Depression 17.72 11.42
 Fatigue 10.56 5.75
 Aggression 14.6 8.25
 Vigor 13.72 4.53
 Confusion 8.66 4.45
 Total score 55.46 37.21
Ferrans and Powers Quality of Life Indexb
 Health and functioning 16.02 2.44
 Psychological and spiritual 17.19 2.6
 Social and economic 16.31 2.45
 Family 19.05 2.71
 Total score 16.74 2.18
a Value range from –24 to 177, with higher scores indicating a greater 
disturbance in mood
b Value range from 0–30, with high scores indicating better quality of 
life
TABLE 3. Comparison of Quality of Life and Mood 
According to Stage of Breast Cancer
Mooda Quality of Lifeb
Stage
—
X    SD
—
X    SD
I 29.66 32.4 17.72 2.22
II 62.13 35.33 16.79 2.03
III 70.25 35.8 15.08 1.74
a Analysis of variance = 4.85, p = 0.015
b Analysis of variance = 4.05, p = 0.024
Clinical Journal of Oncology Nursing  •  Volume 16, Number 3  •  Quality of Life and Mood State After Mastectomy E121
greater the mood disturbance, the poorer QOL participants had. 
That correlation could be related to body alteration. Mangani-
ello et al. (2011) stated that a mastectomy negatively changes 
patients’ self-image and self-esteem and, consequently, causes 
depression and anxiety. Some patients may experience more 
severe changes, particularly in body image, after a mastectomy 
(Farooqi, 2005; Han et al., 2010; Karakoyun-Celik et al., 2010; 
Manganiello et al., 2011). Previous studies also found that mood 
disturbance may negatively influence the QOL of patients with 
breast cancer (Ferrans & Powers, 1992; Karakoyun-Celik et al., 
2010; Uzun, Aslan, Selimen, & Koc, 2004; Weitzner et al., 1997). 
Burgess et al. (2005) concluded that women with depressive 
symptoms reported low QOL scores in all domains. In that 
study, the sample of women who had undergone a mastectomy 
was selected so that they were 1–5 years post surgery (Burgess 
et al., 2005). According to Karakoyun-Celik et al. (2010), the 
negative impact of a mastectomy on body image continues for 
more than a year after treatment. Manganiello et al. (2011), 
in a study on QOL of patients with breast cancer, noted that 
participants who had a mastectomy reported significantly low 
scores in body image in the first or second year after surgery.
The current study’s results also indicate that QOL is nega-
tively correlated with stage of disease. A more advanced stage 
of disease is associated with poorer QOL, which reflects prior 
findings that the QOL of patients with stage III breast cancer 
were significantly lower than the QOL of patients in stage I or 
II (Weitzner et al., 1997). That may be because the patient with 
more advanced-stage cancer had more symptoms. However, 
Uzun et al. (2004) found no relationship between stage of 
breast cancer and QOL. Some researchers reported significant 
correlations between domains of QOL scale and stage of breast 
cancer. For example, Tercyak et al. (2007) noted an association 
between stage of breast cancer and QOL when patients with 
advanced-stage breast cancer reported poorer QOL, and a 
negative correlation between stage of breast cancer and mood 
state also was demonstrated. Similarly, Weitzner et al. (1997) 
found that patients with stage III breast cancer experienced 
more state anxiety and trait anxiety compared to breast cancer 
survivors. Vahdaninia, Omidvari, and Montazeri (2010) stated 
that patients with locoregional and metastasis stages were at 
higher risk for developing severe anxiety. Robb et al. (2007) 
indicated that psychological disorders, such as anxiety and 
depression, could be predicted by disease stage and breast 
cancer progress and showed disease progress to be a significant 
predictor of psychological disorders. According to Weitzner et 
al. (1997), cancer-related uncertainty and fear of disease recur-
rence may increase emotion-focused coping, leading to less 
flexible coping strategies and, consequently, higher degrees of 
anxiety and distress.
Conclusion
Mastectomies are common surgeries in Iran, and the vast 
majority of Iranian women with breast cancer (83%) have this 
surgery (Najafi et al., 2005). Iranian women do no undergo 
routine screening tests such as self-breast examinations and 
mammograms. Therefore, many of them are referred to the 
physician in an advanced stage of cancer when surgery is often 
the best choice of treatment. According to the current study, 
mood state is a very important element to determine the QOL 
of patients who had undergone a mastectomy. Nurses should 
be aware of mood disturbance symptoms and their potential 
impact on patients’ QOL. The current study suggests the es-
tablishment of a screening system for women who have had 
mastectomies. With the use of screening, nurses would be 
able to evaluate patients’ mood states to identify problems and 
facilitate referral to appropriate services. The results also sug-
gest that, in the search for good care in a multicultural society 
such as the United States, healthcare providers should learn 
about patients from different cultures. 
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